Aspera Biomedicines, Inc. — Federal Contractor Profile
Aspera Biomedicines, Inc. Secures $6.5M in Federal Contracts
Contractor Overview
Total Contract Value: $6,480,000 ($6.5M)
Total Awards: 2
Company Profile
Aspera Biomedicines, Inc. is a federal contractor with a total government contract value of $6.5 million, spanning two contracts with an average size of $32.4 million. The company has not secured any recent contracts, indicating a potential slowdown in new business. Aspera Biomedicines, Inc. does not have a specific relationship with any government agencies, as no top agency clients are listed. The company's sole-source rate is 0%, and there are no competitive contracts, suggesting a reliance on negotiated contracts rather than open competition. The lack of recent contracts and the absence of a clear dependency on any agency may indicate a need for strategic realignment or a focus on niche markets.
Specializations
- Biomedical research
- Pharmaceutical development
- Clinical trials
- Regulatory compliance
- Biotechnology
- Medical device testing
- Healthcare consulting
- Biological product manufacturing
- Pharmacology
- Genetic engineering
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0%
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 50%
Competitive Position
Aspera Biomedicines, Inc. operates in a niche market, focusing on biomedical and pharmaceutical research and development. While the company has not secured any competitive contracts, its reliance on negotiated sole-source contracts suggests a strong relationship with specific government agencies. However, the lack of recent contracts and the absence of a clear dependency on any agency may indicate a need for strategic realignment or a focus on niche markets.
Value to Taxpayers
Aspera Biomedicines, Inc. provides specialized services in biomedical and pharmaceutical research, which are critical for advancing medical knowledge and developing new treatments. The company's average contract size of $32.4 million suggests significant investment in each project, which could be seen as a positive for taxpayers. However, the absence of competitive contracts and the lack of recent activity may raise concerns about the company's ability to deliver value consistently.
Agency Relationships
Aspera Biomedicines, Inc. does not have a clear dependency on any specific government agency, as no top agency clients are listed. This may indicate a diversified client base, but the lack of recent contracts and the absence of a clear relationship with any agency could pose risks if the company fails to secure new contracts.
Red Flags
- No recent contracts: The absence of recent contracts may indicate a slowdown in business or challenges in securing new contracts.
- No competitive contracts: The company's reliance on negotiated sole-source contracts suggests a lack of competition, which could lead to higher costs for taxpayers.
- Diversified client base: While a diversified client base can be beneficial, the lack of a clear dependency on any agency may pose risks if the company fails to secure new contracts.
Green Flags
- Sole-source contracts: The company's reliance on negotiated sole-source contracts suggests a strong relationship with specific government agencies, which can be beneficial for securing contracts.
- Specialized services: Aspera Biomedicines, Inc. provides specialized services in biomedical and pharmaceutical research, which are critical for advancing medical knowledge and developing new treatments.
- Diversified client base: The company's lack of dependency on any single agency may indicate a diversified client base, which can help mitigate risks.
Key Contracts
Aspera Biomedicines, Inc. has secured two contracts with an average size of $32.4 million, indicating significant investment in each project. The lack of recent contracts and the absence of a clear dependency on any agency may indicate a need for strategic realignment or a focus on niche markets. The company's specialized services in biomedical and pharmaceutical research are critical for advancing medical knowledge and developing new treatments, which could be seen as a positive for taxpayers. However, the absence of competitive contracts and the lack of recent activity may raise concerns about the company's ability to deliver value consistently.
Frequently Asked Questions
What does ASPERA BIOMEDICINES, INC. do for the federal government?
Aspera Biomedicines, Inc. specializes in biomedical and pharmaceutical research, providing services such as clinical trials, regulatory compliance, and medical device testing. The company's work is critical for advancing medical knowledge and developing new treatments.
How much taxpayer money does ASPERA BIOMEDICINES, INC. receive?
Aspera Biomedicines, Inc. has secured a total of $6.5 million in federal contracts, with an average contract size of $32.4 million. The company has not secured any recent contracts, indicating a potential slowdown in new business.
Is ASPERA BIOMEDICINES, INC. good value for taxpayer money?
Aspera Biomedicines, Inc. provides specialized services in biomedical and pharmaceutical research, which are critical for advancing medical knowledge and developing new treatments. The company's average contract size of $32.4 million suggests significant investment in each project, which could be seen as a positive for taxpayers. However, the absence of competitive contracts and the lack of recent activity may raise concerns about the company's ability to deliver value consistently.
How does ASPERA BIOMEDICINES, INC. win its contracts?
Aspera Biomedicines, Inc. relies on negotiated sole-source contracts, suggesting a strong relationship with specific government agencies. The company has not secured any competitive contracts, indicating a lack of competition in the bidding process.
What agencies use ASPERA BIOMEDICINES, INC. most?
Aspera Biomedicines, Inc. does not have a clear dependency on any specific government agency, as no top agency clients are listed. This may indicate a diversified client base, but the lack of recent contracts and the absence of a clear relationship with any agency could pose risks if the company fails to secure new contracts.
What are the risks of relying on ASPERA BIOMEDICINES, INC.?
The absence of recent contracts and the lack of a clear dependency on any agency may pose risks if the company fails to secure new contracts. The company's reliance on negotiated sole-source contracts suggests a lack of competition, which could lead to higher costs for taxpayers.
How does ASPERA BIOMEDICINES, INC. compare to similar contractors?
Aspera Biomedicines, Inc. operates in a niche market, focusing on biomedical and pharmaceutical research and development. While the company has not secured any competitive contracts, its reliance on negotiated sole-source contracts suggests a strong relationship with specific government agencies. However, the lack of recent contracts and the absence of a clear dependency on any agency may indicate a need for strategic realignment or a focus on niche markets.
Recent Federal Contracts
Aspera Biomedicines, Inc. has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| NASA Awards $3.24M for Nanobioreactor R&D to Aspera Biomedicines | National Aeronautics and Space Administration | $3.2M | N/A |